An Exciting Step Forward: FDA Authorizes Pharmacists to Prescribe Paxlovid to Treat COVID-19
Thursday, 07 July 2022
On July 6, 2022, the Food and Drug Administration (FDA) revised the Emergency Use Authorization for COVID-19 treatment Paxlovid. Under the new authorization, state-licensed pharmacists can now prescribe Paxlovid to eligible patients, amending the previous authorization that required an examination and a prescription from a licensed physician before pharmacists could dispense the treatment. From the
- Published in Blog
No Comments